DGX logo

DGXQuest Diagnostics, Inc.

$204.53
$0.75
(0.37%)
Today
Updated: 11:57 AM EDT
EarningsJul 21
Mkt Cap$22.56B
Vol241,730.00
News
all
press releases
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare
Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare are benefiting from telehealth, AI adoption and growing home-care demand.
Zacks
News Placeholder
More News
News Placeholder
4 Outpatient Home Health Stocks Benefiting From Industry Trends
An aging population and rising telehealth and AI adoption boost demand in the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, LFST and AVAH stand to benefit.
Zacks
News Placeholder
DaVita HealthCare (DVA) Up 0.6% Since Last Earnings Report: Can It Continue?
DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
Encompass Health to Expand WV Footprint With 36-Bed Bridgeport Unit
EHC is expanding its rehabilitation network with a new 36-bed hospital in West Virginia.
Zacks
News Placeholder
Quest Diagnostics (DGX) Upgraded to Buy: Here's What You Should Know
Quest Diagnostics (DGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks
News Placeholder
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
News Placeholder
Are Medical Stocks Lagging Quest Diagnostics (DGX) This Year?
Here is how Quest Diagnostics (DGX) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.
Zacks
News Placeholder
Why Is Quest Diagnostics (DGX) Down 5% Since Last Earnings Report?
Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
Reasons to Add Align Technology Stock to Your Portfolio Now
ALGN expands Invisalign worldwide and iTero Lumina leads scanner mix, backed by $1.06B cash, yet 2026 ASP expected down 1-2%.
Zacks
News Placeholder
Quest Diagnostics Declares Quarterly Cash Dividend
Quest Diagnostics Declares Quarterly Cash Dividend Quest Diagnostics Declares Quarterly Cash Dividend PR Newswire SECAUCUS, N.J., May 19, 2026 SECAUCUS, N.J., May 19, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of...
PR Newswire
<
1
2
...
>

Advertisement|Remove ads.